Oticon Intent vs ReSound OMNIA miniRIE

The Oticon Intent is a premium behind-the-ear prescription hearing aid released in 2024, priced at $4,898 and earning an A grade with a SoundScore of 4.8/5 in our lab testing. This places it at #4 among 39 prescription hearing aids tested, within the top 8% of its category. In our testing, the Intent demonstrates notable strengths in speech performance, scoring 0.54 points above the category average for speech in quiet and a substantial 0.95 points above average for speech in noise. Music streaming is a particular highlight, measuring 1.24 points above the category average with a strong 4.0/5 score. Feedback handling is excellent at 5.0/5, slightly exceeding the already-high category average. The primary limitation revealed in our testing is own-voice comfort, which scores 1.3/5—a low absolute score that falls 1.40 points below the category average. Users sensitive to the sound of their own voice may find this characteristic noticeable. This is a common trade-off in devices optimized for speech audibility. The Oticon Intent is well-suited for users prioritizing speech understanding across varied listening environments and high-quality audio streaming. It has earned HearAdvisor's Expert's Choice Award in both 2023 and 2024. Shoppers in this premium price tier may also consider the Phonak Sphere Infinio (#2) or the lower-priced Oticon Zeal, which offers strong performance at a reduced cost.

The ReSound OMNIA miniRIE is a premium prescription behind-the-ear hearing aid released in 2022, priced at $4,764. In our lab testing, it earned a SoundScore of 4.0/5 (A grade), ranking #26 of 39 prescription hearing aids tested. This device demonstrates solid speech clarity in quiet environments, scoring 3.7/5—0.26 points above the category average. Own-voice comfort also measures slightly above average at 2.9/5. However, the OMNIA miniRIE struggles in challenging listening situations, with speech-in-noise performance scoring just 1.0/5, which is 1.11 points below the category average and low in absolute terms. This represents a significant limitation for users who frequently encounter noisy environments like restaurants or social gatherings. Feedback handling is strong in absolute terms at 4.1/5, though this falls 0.62 points below the prescription hearing aid category average of 4.72/5. Music streaming performance is mixed at 2.7/5, essentially matching the category average. The device offers modern connectivity features including iPhone and Android streaming, hands-free calling, and rechargeable batteries. While the OMNIA miniRIE has earned Expert's Choice Awards in 2023 and 2024, consumers in this premium price tier should note that several competitors—including the Phonak Sphere Infinio and Oticon Intent—achieve higher overall scores. This hearing aid may be best suited for individuals who prioritize performance in quieter settings and value ReSound's ecosystem, but those needing robust noise management should explore alternatives.